Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

The Realities Reshaping Phase I Trials For Sponsors
Phase I trials increasingly enroll patients and use expansion cohorts. Learn what this shift means for IRB review and sponsor planning.
3 Essential Components Of Successful Renal And Hepatic Impairment Studies
Kidney and liver function affect how drugs work in the body. Learn how impairment studies help set safe, effective dosing for these patients.
Community-Focused Site Networks Transforming Clinical Trials
Leveraging a site network has proven to ease study enrollment, contracting, and budgeting, while also reducing overall study cost and timelines.
The Site AI Playbook: Vendor Tools, Homegrown Solutions & What's Working
Gain a practical framework for evaluating tools, identifying high-impact use cases, and making informed decisions about implementation and vendor selection.

Designed To Help Sites Increase Clinical Trial Capacity
7/25/2025

IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.
Targeted Modalities: Trends, Challenges, CDMO Considerations
8/11/2025

Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.
Dedicated Community Oncology Sites
7/29/2026

Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.
The One Moment You Have Leverage In A Clinical Trial, And Why It Disappears Fast
8/13/2026

Discover how to maintain strategic leverage during vendor selection. Learn to identify flexible, long-term partners who keep clinical trials on track before contracts are signed.
What If Therapeutic Area Expertise Isn't The Competitive Advantage We Think It Is?
8/13/2026

Rethink vendor evaluation by looking beyond indication experience to discover how cross-trial adaptability, proactive risk management, and team judgment drive true clinical trial resilience.

Migraine Research Expertise: A Full-Service Neuroscience CRO

Running a migraine trial? Learn how specialized neuroscience support, from PRO selection to real-time data review, can resolve common study delays and endpoint gaps.
Site And Patient Payments

With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.
Supporting Early Phase Research Through Collaboration

Early phase trials demand speed and precision. Discover a partnership providing specialized expertise that keeps your program on track.
Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
Deliver Supply Without Friction. Maintain Control At Every Step

Learn how clinical supply organizations can reduce manual effort, strengthen compliance, improve global coordination, and maintain control across evolving clinical trial supply chains.